Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
125 participants
OBSERVATIONAL
2024-10-04
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Changes in Bioimpedance During Cardiac Resynchronization Therapy
NCT03640000
Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps
NCT06765226
Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study
NCT05291884
Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study
NCT00500838
Renal Denervation in Heart Failure With Preserved Ejection Fraction
NCT01840059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data Acquisition
Develop algorithms for determining the cardiac output through the synchronous acquisition of hemodynamic data from the pulmonary artery catheter or other pressure sensors and Impella using a network module.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Presence or planned placement of a cardiac output measurement
1. Preferentially pulmonary catheter (including cardiac output (CO) preferred as continuous measurement)
2. Other means of discontinuous CO measurement incl. echocardiography, other thermodilution methods
Exclusion Criteria
2. Pregnancy
3. Anticipated support duration \<24 h
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abiomed Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Kersten, MD
Role: PRINCIPAL_INVESTIGATOR
Uniklinik RWTH Aachen, Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uniklinik RWTH Aachen
Aachen, North Rhine-Westphalia, Germany
UKSH Campus Kiel
Kiel, Schleswig-Holstein, Germany
Asklepios Klinik Altona
Hamburg, , Germany
IRCCS Ospedale San Raffaele
Milan, MI, Italy
Universitätsspital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-R01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.